July 30, 2021
Strezsak v. Ardelyx Inc. et al
Case Number:
4:21-cv-05868
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Freedman Normand
- Glancy Prongay
- Johnson Fistel
- Latham & Watkins
- Pogust Goodhead
- Pomerantz LLP
- Robbins Geller
- Scott&Scott
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 18, 2024
Biotech Ardelyx Beats Shareholder Suit Over Kidney Drug
Biotechnology company Ardelyx Inc. has for now beaten a shareholder class action alleging the company and its top brass made false and misleading statements about regulatory approval of Ardelyx's drug for patients with chronic kidney disease.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
View the parties now
Already a subscriber? Click here to login